...
首页> 外文期刊>Journal of the American College of Surgeons >Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
【24h】

Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.

机译:磁共振成像引导的支架线定位后乳腺癌的再切除率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We performed this study to determine rates of close or transected cancer margins after magnetic resonance imaging-guided bracket wire localization for nonpalpable breast lesions. STUDY DESIGN: Of 243 women undergoing MRI-guided wire localizations, 26 had MRI bracket wire localization to excise either a known cancer (n = 19) or a suspicious MRI-detected lesion (n = 7). We reviewed patient age, preoperative diagnosis, operative intent, mammographic breast density, MRI lesion size, MRI enhancement curve and morphology, MRI Breast Imaging Reporting and Data System (BI-RADS) assessment code, number of bracket wires, and pathology size. We analyzed these findings for their relationship to obtaining clear margins at first operative excision. RESULTS: Twenty-one of 26 (81%) patients had cancer. Of 21 patients with cancer, 12 (57%) had negative margins at first excision and 9 (43%) had close/transected margins. MRI size > or = 4 cm was associated with a higher reexcision rate (7 of 9, 78%) than those < 4 cm (2 of 12, 17%) (p = 0.009). MRI BI-RADS score, enhancement curve, morphology, and preoperative core biopsy demonstrating ductal carcinoma in situ (DCIS) were not predictive of reexcision. The average number of wires used for bracketing increased with lesion size, but was not associated with improved outcomes. On pathology, cancer size was smaller in patients with negative margins (12 patients, 1.2 cm) than in those with close/transected margins (9 patients, 4.6 cm) (p < 0.001). Reexcision was based on close/transected margins involving DCIS alone (6, 67%), infiltrating ductal carcinoma and DCIS (2, 22%), or infiltrating ductal carcinoma alone (1, 11%). Reexcision pathology demonstrated DCIS (3, 33%), no residual cancer (5, 55%), and 1 patient was lost to followup (1, 11%). Interestingly, cancer patients who required reexcision were younger (p = 0.022), but breast density was not associated with reexcision. CONCLUSIONS: To our knowledge, this is the first report of MRI-guided bracket wire localization. Patients with MRI-detected lesions less than 4 cm had clear margins at first excision; larger MRI-detected lesions were more likely to have close/transected margins. Reexcision was often because of DCIS and was the only pathology found at reexcision, perhaps because MRI is more sensitive for detecting invasive carcinoma than DCIS.
机译:背景:我们进行了这项研究,以确定在不可触及的乳腺病变的磁共振成像引导下的支架线定位后,癌边缘的闭合或横切率。研究设计:在243位接受MRI引导线定位的女性中,有26位进行了MRI支架线定位以切除已知的癌症(n = 19)或可疑的MRI检测到的病变(n = 7)。我们审查了患者年龄,术前诊断,手术意图,乳房X光检查的乳房密度,MRI病变大小,MRI增强曲线和形态,MRI乳房成像报告和数据系统(BI-RADS)评估代码,支架线的数量以及病理尺寸。我们分析了这些发现与它们在首次手术切除时获得明确切缘的关系。结果:26名患者中有21名(81%)患有癌症。在21例癌症患者中,有12例(57%)初次切缘阴性,9例(43%)切缘近缘/横切。 MRI尺寸大于或等于4 cm的患者与小于4 cm的患者(2 of 12,17%)的再切除率(9/7,78%)相关(p = 0.009)。 MRI BI-RADS评分,增强曲线,形态和术前核心活检证实导管原位癌(DCIS)不能预测切除术。用于托槽的平均线数随病变大小而增加,但与改善结局无关。在病理学上,切缘阴性的患者(12例,1.2厘米)的癌症大小小于切缘闭合/横切的患者(9例,4.6厘米)(p <0.001)。再次切除是基于仅涉及DCIS(6,67%),浸润性导管癌和DCIS(2,22%)或仅浸润性导管癌(1,11%)的闭合/横切缘。切除病理证实为DCIS(3,33%),无残留癌(5,55%),且有1例患者失去随访(1,11%)。有趣的是,需要切除的癌症患者较年轻(p = 0.022),但乳房密度与切除无关。结论:据我们所知,这是MRI引导下支架线定位的首次报道。 MRI检测到的病变小于4 cm的患者在第一次切除时有明显的切缘。较大的MRI检测到的病变更有可能具有闭合/横切的边缘。再次切除通常是由于DCIS引起的,并且是再次切除时发现的唯一病理,可能是因为MRI比DCIS对检测浸润性癌更敏感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号